J. Barbera (Barcelona, Spain), R. Naeije (Brussels, Belgium)
New markers of endothelial dysfunction in patients with COPD
N. Karoli, A. Rebrov, V. Sergeeva (Saratov, Russian Federation)
|   |
An investigation of correlation between diameter and pressure of pulmonary artery in pulmonary hipertension cases due to biomass smoke
B. Ozbay, B. Sertogullarindan, S. Avcu, Y. Gunes (Van, Turkey)
| |
Early pulmonary hemodynamical changes in systemic sclerosis. A one-year follow-up
G. Kovacs, R. Maier, E. Aberer, M. Brodmann, W. Graninger, S. Scheidl, C. Hesse, N. Troester, E. Gruenig, H. Olschewski (Graz, Austria; Heidelberg, Germany)
| |
Efficacy of oral add-on therapy in patients with pulmonary hypertension
G. Prevot, L. Têtu, B. Degano, A. Didier (Toulouse, Montauban, France)
| |
BNP levels are related to NYHA functional class and haemodynamic variables in pulmonary hypertension prior vasoactive treatment
G. Prevot, L. Tetu, N. Blot-Souletie, A. Didier (Toulouse, France)
| |
Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension
Y. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenko, A. V. Volkov, I. Y. Chazova (Moscow, Russian Federation)
| |
Endothelial dysfunction in patients with COPD: flow-mediated vasodilatation and ET-1 level. What method is more informative?
E. Lukina, A. Gichkin, A. Alexandrov, V. Perley, N. Kuzubova (Saint-Petersburg, Russian Federation)
| |
Longer-term survival in paediatric patients with idiopathic or familial pulmonary arterial hypertension treated with bosentan
R. M. F. Berger, M. Beghetti, R. J. Barst, X. Jais, P. Acar, A. Fraisse, D. D. Ivy, I. Schulze-Neick, D. Bonnet, S. G Haworth (Groningen, Netherlands; Geneva, Switzerland; New York, Denver, United States Of America; Clamart, Toulouse, Marseille, Paris, France; London, United Kingdom)
| |
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
C. Church, A. Peacock, M. Johnson (Glasgow, United Kingdom)
| |
Six minute treadmill test as a new endpoint in pulmonary hypertension
M. van der Plas, R. van steenwijk, P. Sterk, P. Bresser (Amsterdam, Netherlands)
| |
Exercise capacity and pulmonary circulation in sherpas vs aCCLimatized lowlanders at high altitude
V. Faoro, M. Lamotte, S. Huez, K. Retailleau, J. B. Martinot, C. De Bisschop, R. Naeije (Brussels, Namur, Belgium; Poitiers, France)
| |
Exercise tolerability in children with pulmonary arterial hypertension (PAH), a population pk/pd assessment of the effects of sildenafil
L. Harnisch, N. Hayashi (Sandwich, United Kingdom)
| |
Long-term outcome of patients with portopulmonary hypertension treated with sildenafil
F. Reichenberger, R. Voswinckel, E. Steveling, F. Lehndeckel, H. Gall, W. Seeger, H. A. Ghofrani (Giessen, Germany)
| |
Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study
K. Portillo, E. Sala, J. S. Roman, J. Gaudó, A. B. Villar, M. Brand, D. Rosenberg, X. Llòria, D. Aubert, A. Román, J. A. Barberà (Barcelona, Palma de Mallorca, Seville, Madrid, Pontevedra, Spain; Allschwil, Switzerland; Paris, France)
| |
A study of pulmonary parenchymal and vascular disease in patients with familial Mediterranean fever (fmf)
N. Mogulkoc, S. Bayraktaroglu, A. Dirican, M. Kayikcioglu, Y. Kabasakal (Bornova-Izmir, Turkey)
| |
Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain
J. Mazo, E. Sala, J. A. Barberà, J. Segovia, L. Molina, J. M. Arizón, M. Brand, D. Rosenberg, X. Llòria, D. Aubert, M. J. R. Pura (Bilbao, Palma de Mallorca, Barcelona, Madrid, Córdoba, Seville, Spain; Allschwil, Switzerland; Paris, France)
| |
Studying the pulmonary capillary bed: relation between pulmonary capillary blood flow (Qs) and capillary blood volume (Vc). Data from the PROOF study
L. Bertoletti, N. Glas, F. Roche, J. C. Barthelemy, F. Costes (Saint-Etienne, France)
| |
Measure of resting pulmonary blood flow measured by acetylene washout in healthy aged subjects and comparison with cardiac output. The PROOF study
L. Bertoletti, S. BAYLE, L. Bisch, Y. Jamon, F. Roche, J. C. Barthelemy, F. Costes (Saint-Etienne, France)
| |
Evaluation of the pulmonary blood flow and cardiac output via non-invasive hemodynamic measurement in young healthy volunteers
K. Dolp, S. Desole, C. M. Kähler (Innsbruck, Austria)
| |
Accuracy of echocardiography to detect pulmonary hypertension in severe COPD
A. Tiotiu, C. Selton-Suty, E. Gomez, F. Chabot, A. Chaouat (Vandoeuvre-les-Nancy, France)
| |